Emc Capital Management Nkarta, Inc. Transaction History

Emc Capital Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$8.66 - $14.99 $108,665 - $188,094	-12,548 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$23.94 - $36.68 $82,449 - $126,325	3,444 Added 37.83%	12,548 $398,000
Q1 2021 May 05, 2021	SELL	$31.33 - $59.61 $119,429 - $227,233	-3,812 Reduced 29.51%	9,104 $300,000
Q4 2020 Feb 24, 2021	BUY	$27.03 - $75.62 $349,119 - $976,707	12,916 New	12,916 $794,000

129

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $127M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Emc Capital Management, based on Form 13F filings with the SEC.

Stay updated on Emc Capital Management with notifications on news.